Answers are grounded in this paper and cite their sources.
This research demonstrates an anticancer agent using photoresponsive Ir(III) complexes, suggesting new PDT strategies.
Herein, we report photoinduced 2,2’-bipyrimidine-based mono and binuclear cyclometalated Iridium (III) complexes as a future promising anticancer agent exhibiting the best efficiency as a Type I and Type II PDT...
No takes yet. Share an insight, caveat, or question.
Sreelekha et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: